Outcomes of treatment, laboratory results, adverse effects, and tolerability of cancer treatment in patients with metastatic renal-cell carcinoma treated with sunitinib after cytoreductive nephrectomy

INTRODUCTION: This publication aims to present the results of a retrospective analysis of the treatment outcomes of patients with metastatic renal-cell carcinoma (RCC) who underwent cytoreductive nephrectomy (CN) followed by systemic treatment with sunitinib. MATERIAL AND METHODS: The retrospective...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Maciej Michalak, Piotr Tomczak, Tomasz Milecki, Andrzej Antczak
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Via Medica 2024-05-01
Edice:	Nowotwory
Témata:	sunitinib metastatic renal-cell carcinoma cytoreductive nephrectomy CARMENA SURTIME
On-line přístup:	https://journals.viamedica.pl/nowotwory_journal_of_oncology/article/view/98971
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!